Fundraising Fox4Bio Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
NV Therapeuticsnvtx.bioinMar 2025SEC filingmedium confidence
NV Therapeutics develops non-viral gene therapies designed to be safe, effective, and scalable.
BiotechDeep TechMedical DevicesBerkeley, US
Jake Lamson(Co-Founder & Director of Synthetic Biology)Adrian Thrasher(Scientific Co-Founder & Advisor)Donald Kohn(Scientific Co-Founder & Advisor)Giorgia Santilli(Scientific Co-Founder & Advisor)Dima Kuzmin(Board Director & Scientific Co-Founder)inKevin Holden(CEO & Co-Founder)in
Board seatDmitry Kuzmin· per SEC Form D · $7.5M raise · filed Mar 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.